We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1951:TSEJinxin Fertility Group Limited Analysis

Data as of 2026-05-27 - not real-time

¥2,831.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at ¥2,831, comfortably above its 20‑day (¥2,864.8), 50‑day (¥2,802.3) and 200‑day (¥2,503.3) simple moving averages, underscoring a clear bullish bias. Technical momentum is reinforced by a 30‑day volatility of nearly 30% and an exceptionally low beta of 0.09, indicating the share moves largely independent of broader market swings. The Relative Strength Index sits at 50.1, suggesting the price is neither overbought nor oversold. However, the MACD line is deep in negative territory (‑12.46) and the histogram remains bearish (‑14.92), hinting at a possible short‑term correction. The price remains safely above the identified support at ¥2,645 and has room to test the resistance near ¥3,058.
On the fundamentals side, revenue grew 15.2% YoY, delivering a gross margin of 14.6% and an operating margin of 8.7%, which is respectable for the engineering‑construction sector. The forward P/E of 23.9 versus the industry average of 30.1 positions the stock as a relative value play. A 2.84% dividend yield with a 45% payout ratio signals reasonable sustainability given the company’s ¥41.7 bn cash pile, though total debt of ¥137.2 bn yields a debt‑to‑equity of 39.6, warranting monitoring. The discounted cash‑flow model places fair value at ¥2,483, implying the market is pricing a modest premium of roughly 2% over intrinsic value. The “Extreme Greed” reading on the Fear & Greed Index (91) reflects strong investor appetite, which could amplify short‑term price swings.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above key moving averages
  • Bearish MACD histogram suggests near‑term pullback
  • Support level provides downside cushion

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • 15% YoY revenue growth
  • Dividend yield above 2% with sustainable payout
  • Valuation discount to industry P/E

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Low beta implies defensive profile
  • Stable dividend stream
  • High debt level requires watchful balance‑sheet management

Key Metrics & Analysis

Financial Health

Revenue Growth15.20%
Profit Margin3.94%
P/E Ratio18.7
ROE9.20%
ROA4.88%
Debt/Equity39.58
P/B Ratio1.7
Op. Cash Flow¥33.2B
Free Cash Flow¥24.6B
Industry P/E30.1

Technical Analysis

TrendBullish
RSI50.1
Support¥2,645.00
Resistance¥3,058.00
MA 20¥2,864.80
MA 50¥2,802.31
MA 200¥2,503.29
MACDBearish
VolumeIncreasing
Fear & Greed Index91.05

Valuation

Fair Value¥2,482.99
Target Price¥2,780.00
Upside/Downside-1.80%
GradeOvervalued
TypeBlend
Dividend Yield2.84%

Risk Assessment

Beta0.09
Volatility29.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.